SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Kottmann Sherri

(Last) (First) (Middle)
C/O FORRESTER RESEARCH, INC.
60 ACORN PARK DRIVE

(Street)
CAMBRIDGE MA 02140

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2019
3. Issuer Name and Ticker or Trading Symbol
FORRESTER RESEARCH, INC. [ FORR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief People Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 978 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non Qualified Stock Option (Right to Buy) 04/01/2015 06/30/2021 Common Stock 500 33.03 D
Non Qualified Stock Option (Right to Buy) 05/14/2016 05/13/2022 Common Stock 1,000 33.81 D
Non Qualified Stock Option (Right to Buy) 07/02/2016 07/01/2022 Common Stock 1,500 34.18 D
Non Qualified Stock Option (Right to Buy) 03/01/2017 02/28/2023 Common Stock 500 27.55 D
Non Qualified Stock Option (Right to Buy) 06/03/2017 06/02/2023 Common Stock 1,500 36.18 D
Non Qualified Stock Option (Right to Buy) 03/03/2018 03/02/2024 Common Stock 500 35.94 D
Non Qualified Stock Option (Right to Buy) 08/01/2018 07/31/2024 Common Stock 500 38.43 D
Non Qualified Stock Option (Right to Buy) 08/03/2019 08/02/2025 Common Stock 1,250 33.16 D
Non Qualified Stock Option (Right to Buy) (1) 08/31/2026 Common Stock 3,500 40.75 D
Restricted Stock Units (2) (2) Common Stock 104 (3) D
Restricted Stock Units (4) (4) Common Stock 504 (3) D
Restricted Stock Units (5) (5) Common Stock 681 (3) D
Explanation of Responses:
1. The Options become exercisable in four equal installments on the first, second, third, and fourth anniversaries of the grant date.
2. Unless earlier forfeited under the terms of the RSU, the award vests and converts into common stock on August 3, 2019.
3. Each Restricted Stock Unit represents the right to receive, following vesting, one share of Forrester Research, Inc. common stock.
4. Unless earlier forfeited under the terms of the RSU, the award vests and converts into common stock in three equal installments on August 1, 2019, August 1, 2020, and August 1 , 2021.
5. Unless earlier forfeited under the terms of the RSU, the award vests and converts into common stock in four equal installments on August 1, 2019, August 1, 2020, August 1 , 2021 and August 1, 2022.
Remarks:
Maite Garcia, attorney-in-fact for Sherri Kottman 04/01/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS


I hereby constitute and appoint each of Ryan Darrah, Maite Garcia and Jed
Rosenkrantz signing singly, my true and lawful attorney-in-fact to:

(1)	execute for and on my behalf, in my capacity as an officer and/or director
of Forrester Research, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with
Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)	do and perform any and all acts for and on my behalf that may be necessary
or desirable to complete and execute any such Form 3, 4 or 5 and timely file
such form with the United States Securities and Exchange Commission and any
stock exchange or similar authority; and

(3)	take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be to my benefit,
in my best interest, or that I am legally required to do, it being understood
that the documents executed by such attorney-in-fact on my behalf pursuant to
this Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in-fact's
discretion.

I hereby grant to such attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper
to be done in the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as I might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted.  I acknowledge that the
attorney-in-fact, in serving in such capacity at my request, are not assuming,
nor is the Company assuming, any of my responsibilities to comply with Section
16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until I am no
longer required to file Forms 3, 4 and 5 with respect to my holdings of and
transactions in Company securities, unless I earlier revoke it in a signed
writing delivered to the attorneys-in-fact. Upon signature of this Power of
Attorney, I hereby revoke all previous powers of attorney granted concerning the
subject matter herein.

IN WITNESS WHEREOF, I have caused this Power of Attorney to be executed as of
this March 26, 2019.


/S/Sherri Kottmann
Signature

Sherri Kottman
Print Name